Change theme to redChange theme to blueChange theme to greenChoose your color
 

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@mail.mil



TWO PHASE BIOACTIVE FORMULATIONS

The present invention relates to two phase systems of a bioactive ingredient in particle form that has limited or no solubility in a liquid medium, which provides stability to the bioactive ingredient that is similar to the bioactive ingredient when in the solid state. The bioactive ingredient may be capable of therapeutically treating for the presence of a cholinesterase inhibitor. The bio active ingredient comprises 1,1'-methlyenebis[4-[(hydroxyimino)methyl]-pyridinium]dimethane- sulfonate.


Docket:CBMS 2009-42

Publication/Issued No.:8,722,706

Publication/Issue Date:2015-05-13

Categories: Method

More Detail:Visit USPTO.GOVExternal link

Lab:CBMS

Inventor(s):UNDERWOOD, P.; DIXON, H.; MCDONOUGH, J.; CABELL, L.


For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@mail.mil
 

iSalute

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRMC Public Affairs Office at:
usarmy.detrick.medcom-usamrmc.list.webmaster@mail.mil or by telephone at (301)619-2736